Keyphrases
Rickettsia Amblyommatis
100%
Rocky Mountain Spotted Fever
100%
Brown Dog Tick
100%
Rickettsia Rickettsii
100%
Illness
36%
Case Fatality Rate
27%
Guinea pig
27%
Human Population
18%
Break the Cycle
18%
Live Vaccine
18%
Canine Vaccination
18%
Immune Response
18%
Severe Disease
9%
Tick-borne Diseases
9%
Latin America (LATAM)
9%
Dermacentor Ticks
9%
Canine
9%
Repletion
9%
Neurological Death
9%
Vaccine-induced Immunity
9%
Sporadic Cases
9%
Lethal Dose
9%
Infection Rate
9%
Rapid Onset
9%
High Incidence
9%
Bacteremia
9%
Inoculation
9%
Nymph
9%
Post-antibiotic Era
9%
Mexico
9%
Infestation
9%
Sylvatic Cycle
9%
Frequent Hospitalization
9%
Clinical Disease
9%
Severe Manifestations
9%
Vaccination
9%
Immunization Impact
9%
Clinical Status
9%
Laboratory Testing
9%
Population at Risk
9%
Severe Acute
9%
Free-roaming
9%
Arizona
9%
Laboratory Values
9%
Dermacentor
9%
Blood Specimen
9%
Familial Clustering
9%
Safety Response
9%
Respiratory Failure
9%
Disease Symptoms
9%
Dog Vaccine
9%
Clinical Death
9%
Pragmatic Approach
9%
Infectious Diseases
9%
Life Stages
9%
Neurological Deficit
9%
Hyperendemic
9%
Acute Kidney Injury
9%
United States
9%
Northern Mexico
9%
Public Health Risk
9%
Laboratory Assays
9%
Humoral Immune Response
9%
Immunization
9%
Unvaccinated
9%
Amplifying Host
9%
Immunology and Microbiology
Rickettsia amblyommatis
100%
Rickettsia rickettsii
100%
Rhipicephalus sanguineus
100%
Guinea Pig
75%
Case Fatality Rate
75%
Attenuated Vaccine
50%
Live Vaccine
50%
Immune Response
50%
Dermacentor
50%
Molting
25%
Infection Rate
25%
Face
25%
Nymph
25%
Humoral Immunity
25%
Laboratory Test
25%
Sylvatic
25%